Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03220035
What this trial is testing

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+20 more
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT01118078
What this trial is testing

Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor

Who this might be right for
Clear Cell Sarcoma of the KidneyRecurrent Wilms Tumor and Other Childhood Kidney TumorsRhabdoid Tumor of the Kidney+5 more
Children's Oncology Group 185
Not applicableStudy completedNCT04308642
What this trial is testing

Study to Evaluate Blood and Urine Kidney Injury Markers to Facilitate Early Detection of Renal Adverse Drug Events in Pediatric Cancer Patients Treated With Nephrotoxic Chemotherapy

Who this might be right for
Kidney Impairment
University Hospital, Basel, Switzerland 6
Testing effectiveness (Phase 2)Study completedNCT00113529
What this trial is testing

Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Pfizer 42
Testing effectiveness (Phase 2)Ended earlyNCT02089802
What this trial is testing

Optimizing Pazopanib Exposure in RCC Patients

Who this might be right for
Locally Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Interessenverband zur Qualitätssicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland e. 6
Early research (Phase 1)Study completedNCT00070070
What this trial is testing

Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas

Who this might be right for
Transitional Cell Carcinoma
Ludwig Institute for Cancer Research 6
Large-scale testing (Phase 3)Ended earlyNCT00540969
What this trial is testing

Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer+2 more
Alliance for Clinical Trials in Oncology 3
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Testing effectiveness (Phase 2)Ended earlyNCT04495894
What this trial is testing

Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma

Who this might be right for
Non-small Cell Lung CancerRenal Cell Carcinoma
Emory University 68
Not applicableStudy completedNCT05230186
What this trial is testing

A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.

Who this might be right for
Solid Tumor, Adult
TScan Therapeutics, Inc. 12
Not applicableUnknownNCT04946266
What this trial is testing

Prospective Validation of the Prognostic Value of Long Non-coding MFI2-AS1 RNA in Localized Clear Cell Kidney Cancers

Who this might be right for
Kidney Cancer
University Hospital, Strasbourg, France 260
Testing effectiveness (Phase 2)Study completedNCT05485896
What this trial is testing

Neoadjuvant Therapy of Pembrolizumab Plus Lenvatinib in Advanced RCC

Who this might be right for
Renal Cell Carcinoma
Tianjin Medical University Second Hospital 23
Large-scale testing (Phase 3)Ended earlyNCT04588246
What this trial is testing

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more
NRG Oncology 19
Large-scale testing (Phase 3)Active Not RecruitingNCT01224288
What this trial is testing

Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT01435122
What this trial is testing

Axitinib in Advanced Carcinoid Tumors

Who this might be right for
Carcinoid Tumor
H. Lee Moffitt Cancer Center and Research Institute 30
Testing effectiveness (Phase 2)Study completedNCT00779922
What this trial is testing

Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function

Who this might be right for
Multiple MyelomaImpaired Renal Function
Poitiers University Hospital 39
Testing effectiveness (Phase 2)Ended earlyNCT02624388
What this trial is testing

Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)

Who this might be right for
LymphomaChildhood LymphomaSolid Tumor+13 more
University of Virginia 4
Testing effectiveness (Phase 2)Ended earlyNCT00549822
What this trial is testing

Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Massachusetts General Hospital 3
Not applicableLooking for participantsNCT07820566
What this trial is testing

Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers)

Who this might be right for
Kidney CancersBladder CancerProstate Cancer
University Hospital, Strasbourg, France 100
Next Page